MPO-ANCA Associated Vasculitis Following Intravesical BCG Therapy: A Novel Case Report (P11-2.006)

Nikash Shankar; Fatemeh Sadeghifar; Casey Manzanero; Deanna Saylor

doi:10.1212/wnl.0000000000217468

June 9, 2026Neurology

MPO-ANCA Associated Vasculitis Following Intravesical BCG Therapy: A Novel Case Report (P11-2.006)

View at Publisher

Ask AI

Bookmark

Share

Key Points

This report aims to identify mononeuritis multiplex as a complication of intravesical BCG therapy associated with MPO-ANCA vasculitis.
Conducted a case report analysis of a patient following BCG therapy.
Assessed the clinical presentation of symptoms.
Investigated the association between BCG therapy and subsequent vasculitis.
Documented a case of mononeuritis multiplex following intravesical BCG treatment.
Confirmed the presence of perinuclear ANCA in the patient's sera.
Highlighted the need for awareness of this complication in patients receiving BCG therapy.

Ask about this paper

Answers are grounded in this paper and cite their sources.

Implication

Novel case report highlights mononeuritis multiplex as a complication of intravesical BCG therapy, suggesting potential oversight in treatment effects.

Abstract

Recognize mononeuritis multiplex from perinuclear Anti-neutrophil cytoplasmic antibody (ANCA) vasculitis as novel complication of intravesical Calmette–Guérin (BCG).

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Shankar et al. (2026) studied this question.

synapsesocial.com/papers/6a2cf34dfaef96ed7f055c47 https://doi.org/10.1212/wnl.0000000000217468

View at Publisher

Ask AI

Bookmark

Share

MPO-ANCA Associated Vasculitis Following Intravesical BCG Therapy: A Novel Case Report (P11-2.006)

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

MPO-ANCA Associated Vasculitis Following Intravesical BCG Therapy: A Novel Case Report (P11-2.006)

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading